All about Xellia
Relationships are everything
Beyond the molecule
Our vision is to be the world’s leading supplier of APIs. We're expanding our portfolio, broadening our reach, and building the partnerships to deliver more therapies to more patients around the globe — because the world's need for reliable anti-infectives isn't slowing down, and neither are we.
Our mission is to deliver critical medicine, on time, every time - because patients can't wait.
We are Xellia.
Meet the Xellia Executive Committee and our Board of Directors
Leadership teams
Xellia Pharmaceuticals is wholly owned by Novo Holdings A/S since 2013.
More than 120 years of experience in the pharmaceutical industry
Our heritage
Xellia is a world leader in delivering critical care therapies and anti-infective solutions for severe and often life-threatening infections, encompassing Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs).
Join our team
The “all hands on deck” workplace.
At Xellia, you get a rare opportunity. The chance to shape yourself, our company and society.